HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT03937713

Eszopiclone for PTSD

It tested eszopiclone for PTSD.

PTSD, Complex InsomniaBehavioralFrom 18 Years to 65 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Buffalo, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: December 1, 2019
Recruitment status
Completed
Enrollment listed in the registry
53
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03937713
Official title
A Pragmatic Randomized Comparator Trial of Eszopiclone and Brief Behavioral Therapy for Insomnia in CPAP Non Adherent Veterans With PTSD and Complex Insomnia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Buffalo

Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Office of Research and Development, a government agency.

Did this study involve medication?

Yes. The study involved medication, including eszopiclone.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.